pregabalin
Generic: pregabalin
Labeler: direct_rxDrug Facts
Product Profile
Brand Name
pregabalin
Generic Name
pregabalin
Labeler
direct_rx
Dosage Form
CAPSULE
Routes
Active Ingredients
pregabalin 225 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72189-045
Product ID
72189-045_2be8eb66-533f-0815-e063-6294a90a115d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209743
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2020-12-01
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72189045
Hyphenated Format
72189-045
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pregabalin (source: ndc)
Generic Name
pregabalin (source: ndc)
Application Number
ANDA209743 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 225 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (72189-045-30)
- 60 CAPSULE in 1 BOTTLE (72189-045-60)
- 90 CAPSULE in 1 BOTTLE (72189-045-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2be8eb66-533f-0815-e063-6294a90a115d", "openfda": {"unii": ["55JG375S6M"], "rxcui": ["483438", "483442", "483444", "483446", "577127"], "spl_set_id": ["91cf12b1-e1a6-dbc2-e053-2a95a90a8d5d"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (72189-045-30)", "package_ndc": "72189-045-30", "marketing_start_date": "20201201"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (72189-045-60)", "package_ndc": "72189-045-60", "marketing_start_date": "20201201"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (72189-045-90)", "package_ndc": "72189-045-90", "marketing_start_date": "20201201"}], "brand_name": "PREGABALIN", "product_id": "72189-045_2be8eb66-533f-0815-e063-6294a90a115d", "dosage_form": "CAPSULE", "product_ndc": "72189-045", "dea_schedule": "CV", "generic_name": "PREGABALIN", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PREGABALIN", "active_ingredients": [{"name": "PREGABALIN", "strength": "225 mg/1"}], "application_number": "ANDA209743", "marketing_category": "ANDA", "marketing_start_date": "20201201", "listing_expiration_date": "20261231"}